Trial Profile
A Single and Multiple Dose Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2023
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Partial epilepsies; Seizures; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Acronyms Study 052
- Sponsors Eisai Co Ltd
- 06 Feb 2023 Results (n=30) published in the Clinical Drug Investigation
- 16 Mar 2019 Results presented at the 120th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 25 Jun 2018 Status changed from active, no longer recruiting to completed.